Schulte Roth & Zabel Hosts Seminar: Shareholder Activism in the UK

Schulte Roth & Zabel (SRZ) is hosting a seminar on Shareholder Activism in the UK today in London. The conference brings together leading activists and advisers involved in sophisticated campaigns. They will discuss the current landscape of the shareholder activism industry in the United Kingdom and continental Europe. The event is by invitation only.

Eleazer Klein, a New York-based SRZ partner and co-chair of the firm’s global Shareholder Activism Group, and Jim McNally, SRZ corporate and funds partner, and a UK-based member of the firm’s global Shareholder Activism Group, will provide a market overview and moderate the panels covering “Current Issues in Activism” and “Activists’ Perspectives.” 

The seminar highlights key players in the industry, including panelists: Anne-Sophie d’Andlau, co-founder of CIAM; Liad Meidar, managing partner and CIO of Gatemore Capital Management LLP; Phillip Meyer, general counsel & chief operating officer of Oasis; Husein Bektic, research manager at Activist Insight; Andrew Honnor, managing partner at Greenbrook Communications; and Cas Sydorowitz, CEO of Georgeson Corporate Advisory.

“This year’s UK activism seminar will focus on lessons learned from the growth of shareholder activism in the UK and continental Europe, and what we can expect as the marketplace continues to evolve,” said Mr. Klein.

Marc Weingarten, SRZ partner and co-chair of the firm’s global Shareholder Activism Group, commented, “Having been advising activists for years in the UK and Europe, we continue to see year-over-year growth in the market and we expect this trend to continue. We are also seeing US-style practices, such as the use of settlement or relationship agreements, gain more traction.” Mr. McNally added, “UK activists are also closely monitoring political developments worldwide and the potential impact on their investments.”

“We are pleased to present today’s seminar. The event features market-leading experts on the current state of activism in the UK,” commented Alan S. Waldenberg, chair of SRZ’s Executive Committee. SRZ is the dominant global law firm for shareholder activism and activist investing. The firm is well-known for handling all types of situations, from the straightforward to the most complex and sophisticated campaigns.

Most recently, SRZ advised: JANA Partners in its campaigns at Tiffany & Co. and Bristol-Myers; Greenlight Capital in its campaign at General Motors; venBio Select Advisor in its campaign at Immunomedics; and Elliott Management its campaigns at Marathon Petroleum and PulteGroup, among other high-profile matters.

SRZ advises activists, “occasional activists,” investment advisers and issuers, providing cutting-edge advice on navigating the maze of applicable laws and regulations in the United Kingdom, United States and Canada, as well as covering markets in continental Europe and other parts of the world. Visit SRZ’s Shareholder Activism Resource Center here.